A patient with severe postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS) received immunotherapy with low-dose naltrexone (LDN) and intravenous immunoglobulin ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

At Marshfield Children’s Hospital, Dr. Dolly Paw-ton, the facility dog, is helping make them happen. One Wausau family sees ...

Monoclonal antibodies (mAb) are a major focus of the pharmaceutical industry, and polyclonal immunoglobulin G (IgG) therapy is used to treat a wide variety of health conditions. As some individuals ...

Suggested thresholds for administering immunoglobulin replacement therapy are generally an immunoglobulin G level of less than 400–500 g/dL or the presence of serious or recurrent infection. 70,98 ...

A newborn survived a rare combination of Jka hemolytic disease and HDFN thanks to early diagnosis and aggressive treatment.

Good evidence that intravenous immunoglobulin treatment within the first 10 days of symptoms reduces coronary artery abnormalities (heart damage) in children with Kawasaki disease. Kawasaki disease is ...

Affinity chromatography based on bacterial immunoglobulin (Ig)-binding proteins represents the cornerstone of therapeutic antibody downstream processing. However, there is a pressing need for more ...

IgG levels against native, unmodified ApoB peptides are reduced in patients with previous myocardial infarction 39,40 compared with matched controls and inversely associated with atherosclerosis.

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...